Figure 2: Overview of imaging biomarkers for oxygen metabolism (CMRO2 and mitoPO2), perfusion (CBV and µCBV), and vascular architecture (MVD and VSI) in brain regions with attenuated NVC, with intact NVC on ipsilateral side to the attenuated NVC within the same patient, and with intact NVC on ipsilateral side to the NVC within the same patient, as well as in control patients without any indication for attenuation of NVC on ipsi- and contralateral side to the lesion, respectively